← Leaderboards
Melvin Edward Medof
Case Western Reserve University
$11,656,658
Attributed
$11,656,658
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$11,656,658 · 7
By mechanism
R01$11,656,658 · 7
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Peter Scott Heeger$92,873,534
- Laura E. Nagy$35,655,521
- Zhongwu Guo$9,004,232
- Henry J Kaminski$13,990,719
Others in their field
Top investigators on “Protein Structure Function”
- Andrzej Joachimiak Joachimiak · University Of Chicago$118,068,363
- Ian A Wilson · Scripps Research Institute, The$94,223,471
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Michael W Weiner · Northern California Institute Res &Educ$81,038,279
- Stephen K Burley · Rutgers University New Brunswick$74,994,995
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$73,742,932
Research focus
Protein Structure FunctionIn VivoLaboratory MouseCellsGlycosylphosphatidylinositolsDecay Accelerating FactorInflammatoryImmuneT-LymphocyteInsightClinical ResearchHuman SubjectComplement PathwayRegulationComplementInflammationKnock-OutPlayPathogenesisAutoantibodiesExperimental Autoimmune EncephalomyelitisBaseInhibitor/AntagonistComplement 3 Convertase
Grant awards (37)
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE$348,700
R01 · FY2019 · AR · contact PI
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE$348,700
R01 · FY2018 · AR · contact PI
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE$348,700
R01 · FY2017 · AR · contact PI
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE$348,700
R01 · FY2016 · AR · contact PI
Local Complement Synthesis and Signaling by Endothelial and Inflammatory Cells$386,612
R01 · FY2015 · HL · contact PI
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE$348,700
R01 · FY2015 · AR · contact PI
Local Complement Synthesis and Signaling by Endothelial and Inflammatory Cells$384,650
R01 · FY2014 · HL · contact PI
Local Complement Synthesis and Signaling by Endothelial and Inflammatory Cells$373,660
R01 · FY2013 · HL · contact PI
Local Complement Synthesis and Signaling by Endothelial and Inflammatory Cells$392,500
R01 · FY2012 · HL · contact PI
Role of DAF in the Complement Cascade$443,224
R01 · FY2009 · AI · contact PI
Role of DAF in the Complement Cascade$72,609
R01 · FY2009 · AI · contact PI
Role of DAF in the Complement Cascade$430,317
R01 · FY2008 · AI · contact PI
Role of DAF in the Complement Cascade$425,872
R01 · FY2007 · AI · contact PI
Pathogenic Mechanisms Underlying Diabetic Retinopathy$334,279
R01 · FY2007 · EY · contact PI
Role of DAF in the Complement Cascade$425,819
R01 · FY2006 · AI · contact PI
Pathogenic Mechanisms Underlying Diabetic Retinopathy$336,161
R01 · FY2006 · EY · contact PI
Protection of Ocular Tissues During Inflammation$261,459
R01 · FY2006 · EY · contact PI
Pathogenic Mechanisms Underlying Diabetic Retinopathy$344,250
R01 · FY2005 · EY
Role of DAF in the Complement Cascade$341,927
R01 · FY2005 · AI
Protection of Ocular Tissues During Inflammation$267,750
R01 · FY2005 · EY
ROLE OF DAF IN THE COMPLEMENT CASCADE AND IN PNH$352,861
R01 · FY2004 · AI
Pathogenic Mechanisms Underlying Diabetic Retinopathy$344,250
R01 · FY2004 · EY
Protection of Ocular Tissues During Inflammation$267,750
R01 · FY2004 · EY
Protection of Ocular Tissues During Inflammation$125,000
R01 · FY2004 · EY
ROLE OF DAF IN THE COMPLEMENT CASCADE AND IN PNH$342,807
R01 · FY2003 · AI
Protection of Ocular Tissues During Inflammation$267,750
R01 · FY2003 · EY
CELL SURFACE ENGINEERING WITH GPI ANCHORED PROTEINS$245,222
R01 · FY2003 · CA
ROLE OF DAF IN THE COMPLEMENT CASCADE AND IN PNH$332,822
R01 · FY2002 · AI
C-TERMINAL PROCESSING OF NASCENT PROPROTEINS$287,773
R01 · FY2002 · DK
Protection of Ocular Tissues During Inflammation$267,750
R01 · FY2002 · EY
CELL SURFACE ENGINEERING WITH GPI ANCHORED PROTEINS$239,341
R01 · FY2002 · CA
ROLE OF DAF IN THE COMPLEMENT CASCADE AND IN PNH$323,127
R01 · FY2001 · AI
C-TERMINAL PROCESSING OF NASCENT PROPROTEINS$279,393
R01 · FY2001 · DK
CELL SURFACE ENGINEERING WITH GPI ANCHORED PROTEINS$233,636
R01 · FY2001 · CA
ROLE OF DAF IN THE COMPLEMENT CASCADE AND IN PNH$283,238
R01 · FY2000 · AI
C-TERMINAL PROCESSING OF NASCENT PROPROTEINS$271,257
R01 · FY2000 · DK
CELL SURFACE ENGINEERING WITH GPI ANCHORED PROTEINS$228,092
R01 · FY2000 · CA